Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Atezolizumab Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum-Containing Therapy

ClinicalTrials.gov ID: NCT02008227

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT02008227. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 18, 2026, 3:48 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Open-Label, Multicenter, Randomized Study to Investigate the Efficacy and Safety of Atezolizumab (Anti-PD-L1 Antibody) Compared With Docetaxel in Patients With Non-Small Cell Lung Cancer After Failure With Platinum Containing Chemotherapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This global, multicenter, open-label, randomized, controlled study evaluated the efficacy and safety of atezolizumab (an anti-programmed death-ligand 1 \[anti-PD-L1\] antibody)compared with docetaxel in participants with locally advanced or metastatic non-small cell lung cancer (NSCLC) after failure with platinum-containing chemotherapy. Participants were randomized 1:1 to receive either docetaxel or atezolizumab. Treatment may continue as long as participants experienced clinical benefit as assessed by the investigator, i.e., in the absence of unacceptable toxicity or symptomatic deterioration attributed to disease progression.

Study identification

NCT ID
NCT02008227
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
1,225 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 11, 2014 (Actual)
Primary completion
Jul 7, 2016 (Actual)
Completion
Jan 9, 2019 (Actual)
Last update posted
Dec 20, 2019

2014 – 2019

United States locations

U.S. sites
59
U.S. states
23
U.S. cities
57
Facility City State ZIP Site status
Comprehensive Blood/Cancer Ctr Bakersfield California 93309 —
Roy & Patricia Disney Family Cancer Center Burbank California 91505 —
St. Jude Heritage Healthcare; Virgiia K.Crosson Can Ctr Fullerton California 92835 —
Kaiser Permanente - Hayward Hayward California 94545 —
Scripps Clinic; Hematology & Oncology La Jolla California 92037-1027 —
Pacific Shores Medical Group Long Beach California 90813 —
Univ of Calif, Los Angeles; Hematology/Oncology Los Angeles California 90095 —
North Valley Hem Onc Med Grp; Thomas&Dorothy Leavey Can Ctr Northridge California 91328 —
Kaiser Permanente - Oakland Oakland California 94611 —
TMPN/ Cancer Care Associates Redondo Beach California 90277 —
Kaiser Permanente - Roseville Roseville California 95661 —
Kaiser Permanente Sacramento Medical Center Sacramento California 95814 —
UC Davis; Comprehensive Cancer Center Sacramento California 95817 —
Kaiser Permanente - San Francisco (2238 Geary) San Francisco California 94115 —
K. Permanente - San Jose San Jose California 95119 —
Coastal Integrative Cancer Care San Luis Obispo California 93401 —
Kaiser Permanente - San Marcos San Marcos California 92069 —
K. Permanente - Santa Clara Santa Clara California 95051 —
Central Coast Medical Oncology Santa Maria California 93454 —
K. Permanente - S. San Fran South San Francisco California 94080 —
Kaiser Permanente - Vallejo Vallejo California 94589 —
K. Permanente - Walnut Creek Walnut Creek California 94596 —
St. Mary's Hospital Regional Cancer Center Grand Junction Colorado 81501 —
Kaiser Permanente - Franklin; Kaiser Permanente - Lone Tree Lone Tree Colorado — —
Cancer Specialists; North Florida ;Jacksonville (AC Skinner Pkwy) Jacksonville Florida 32256 —
AMPM Research Clinic Miami Florida 33145 —
Orlando Health Inc. Orlando Florida 32806 —
Georgia Cancer Specialists Atlanta Georgia 30341 —
Ingalls Memorial Hospital Harvey Illinois 60426 —
Illinois Cancer Care Peoria Illinois 61615 —
Quincy Medical Group Quincy Illinois 62301 —
Hematology-Oncology; Associates of the Quad Cities Bettendorf Iowa 52722 —
New England Cancer Specialists Scarborough Maine 04074 —
Karmanos Cancer Inst. ; Hudson Webber; Cancer Research Building Detroit Michigan 48201 —
US Oncology Research at Minnesota Oncology Minneapolis Minnesota 55404 —
University of Minnesota Minneapolis Minnesota 55455 —
Billings Clinic; Research Center Billings Montana 59101 —
Montana Cancer Specialists Missoula Montana 59802 —
Oncology Hematology West Midwest Omaha Nebraska 68130 —
Comprehensive Cancer Centers of Nevada Henderson Nevada 89014 —
Comprehensive Cancer Centers of Nevada - Eastern Avenue Las Vegas Nevada 89169 —
Summit Medical Center Florham Park New Jersey 07932 —
Luckow Pavillion, Valley Hosp; Office of Clinical Trials Paramus New Jersey 07652 —
San Juan Oncology Associates Farmington New Mexico 87401 —
Roswell Park Cancer Inst. Buffalo New York 14263 —
New York Oncology Hematology PC - Latham Clifton Park New York 12065 —
Mid Ohio Onc Hematology Inc Columbus Ohio 43219 —
Cancer Treatment Centers of America-Tulsa Tulsa Oklahoma 74133 —
Willamette Valley Cancer Ctr - 520 Country Club Eugene Oregon 97401-8122 —
Rhode Island Hospital Providence Rhode Island 02903 —
Texas Onc-Central Austin CA Ct Austin Texas 78731 —
The Methodist Cancer Center Houston Texas 77030 —
Texas Oncology, P.A. - Tyler; Tyler Cancer Center Tyler Texas 75702 —
Virginia Cancer Specialists, PC Fairfax Virginia 22031 —
Virginia Oncology Associates Norfolk Virginia 23502 —
Blue Ridge Cancer Care Roanoke Virginia 24014 —
Northwest Medical Specialties Tacoma Washington 98405 —
Northwest Cancer Specialists - Vancouver Vancouver Washington 98684 —
Aurora Health Care; Patient Centered Research Milwaukee Wisconsin 53215 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 149 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02008227, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 20, 2019 · Synced Nov 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.